Probiotics for aggregation with disease-associated species in the oral cavity
AssigneesSymrise AG, Probi AB
InventorsMarcus Rudolf Götz, Kerstin Holmgren, Niklas Larsson, Bernd Fiebich, William Wade
Life of this patent
Estimating the term…
Loading patent…
AssigneesSymrise AG, Probi AB
InventorsMarcus Rudolf Götz, Kerstin Holmgren, Niklas Larsson, Bernd Fiebich, William Wade
Estimating the term…
The present invention relates to certain microorganisms or mixtures thereof for use in the treatment and/or prevention of inflammation in the oral cavity, preferably for the treatment and/or prevention of gingivitis and/or peridontitis. In particular, the present invention relates to microorganisms or mixtures thereof for use as probiotic agents for forming co-aggregates with microorganisms associated with gingivitis and/or peridontitis. Furthermore, the present invention provides oral pharmaceutical compositions, oral care products or products for nutrition or pleasure comprising one or more of the probiotic microorganisms as active agents as well as a method of production thereof.
A method for treating gingivitis and/or periodontitis comprising orally administering to a subject a microorganism or a mixture of two or more microorganisms selected from the group consisting of Lactobacillus delbrueckii subsp. lactis LL-G41 (CCTCC M 2016652), Lactobacillus fermentum 35D (DSM 32130), Lactobacillus gasseri NS8 (NCIMB 11718), Lactobacillus salivarius NS 12 (NCIMB 8816), Streptococcus salivarius NS18 (CBS 142430), and Streptococcus salivarius NS19 (CBS 142431).
Dependencies are inferred from the claim text.